Adult survivors of childhood cancer demonstrate significantly higher mortality compared to the general population, out of proportion to the rate of recurrence for their primary cancer.
Study authors stated that their findings may contribute to personalized treatment decisions in the future, though additional studies are needed for confirmation.
CTA asked Dr Wiemels about emerging evidence that viral infection might play an important role in childhood leukemogenesis.
Younger patients with non-small cell lung cancer (NSCLC) may have a distinct disease, genetically and biologically.
Survivors of childhood cancer are at increased risk for treatment-related subsequent neoplasms (SNs), even after age 40 years.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Finding Clinical Trials in Cancer
- Adding Nintedanib Did Not Improve Survival in Lung Cancer Subtype
- The Identification of a Potential Early Plasma Biomarker for Kidney Cancer
- Pembrolizumab Plus Chemotherapy Extended Survival Longer Than Chemotherapy Alone: Study
- Combining Chemotherapy With Checkpoint Inhibitors Extends Overall Survival in ES-SCLC
- In a Head-to-Head Battle, Brigatinib Appears to Best Crizotinib